Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists

Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics - ScienceDirect

Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction

Design, synthesis and biological evaluation of novel pyrazolopyrimidone derivatives as potent PDE1 inhibitors - ScienceDirect

One-Pot 1,1-Dihydrofluoroalkylation of Amines Using Sulfuryl Fluoride

PDF) S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

Kelly Dong's research works China FAW Group Corpration R&D Center, Jilin and other places

Design, synthesis and biological evaluation of novel pyrazolopyrimidone derivatives as potent PDE1 inhibitors - ScienceDirect

Scholarly article on 2-hydroxy-6-(((4-methoxybenzyl)oxy)methyl)benzaldehyde 1035402-44-8 from Organic Letters p. 4936 - 4939

Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs)

Discovery, structure-activity relationship study and biological evaluation of 2-thioureidothiophene-3-carboxylates as a novel class of C-X-C chemokine receptor 2 (CXCR2) antagonists - ScienceDirect

Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts

Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists

Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics - ScienceDirect

Xichen Lin's research works China Academy of Building Research Shanghai Branch, Shanghai and other places